NO983926D0 - Farmasöytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretslöpsykdommer - Google Patents

Farmasöytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretslöpsykdommer

Info

Publication number
NO983926D0
NO983926D0 NO983926A NO983926A NO983926D0 NO 983926 D0 NO983926 D0 NO 983926D0 NO 983926 A NO983926 A NO 983926A NO 983926 A NO983926 A NO 983926A NO 983926 D0 NO983926 D0 NO 983926D0
Authority
NO
Norway
Prior art keywords
inhibitor
drug
sodium
treatment
pharmaceutical composition
Prior art date
Application number
NO983926A
Other languages
English (en)
Other versions
NO983926L (no
NO320264B1 (no
Inventor
Wolfgang Scholz
Udo Albus
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of NO983926D0 publication Critical patent/NO983926D0/no
Publication of NO983926L publication Critical patent/NO983926L/no
Publication of NO320264B1 publication Critical patent/NO320264B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO19983926A 1997-08-27 1998-08-26 Farmasoytisk kombinasjonspreparat omfattende en inhibitor av natrium-hydrogen-utveksler og en handelspakning omfattende dette. NO320264B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737224A DE19737224A1 (de) 1997-08-27 1997-08-27 Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen

Publications (3)

Publication Number Publication Date
NO983926D0 true NO983926D0 (no) 1998-08-26
NO983926L NO983926L (no) 1999-03-01
NO320264B1 NO320264B1 (no) 2005-11-14

Family

ID=7840257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983926A NO320264B1 (no) 1997-08-27 1998-08-26 Farmasoytisk kombinasjonspreparat omfattende en inhibitor av natrium-hydrogen-utveksler og en handelspakning omfattende dette.

Country Status (23)

Country Link
US (1) US6348476B1 (no)
EP (1) EP0937464B1 (no)
JP (1) JP4436940B2 (no)
KR (1) KR19990023904A (no)
CN (1) CN1172665C (no)
AR (1) AR017513A1 (no)
AU (1) AU738598B2 (no)
BR (1) BR9803233A (no)
CA (1) CA2245776A1 (no)
CZ (1) CZ270998A3 (no)
DE (1) DE19737224A1 (no)
HK (1) HK1018211A1 (no)
HR (1) HRP980464A2 (no)
HU (1) HUP9801924A3 (no)
IL (1) IL125913A0 (no)
NO (1) NO320264B1 (no)
NZ (1) NZ331533A (no)
PL (1) PL195566B1 (no)
RU (1) RU2227751C2 (no)
SK (1) SK116798A3 (no)
TR (1) TR199801661A2 (no)
TW (1) TW589175B (no)
ZA (1) ZA987723B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945302A1 (de) * 1999-09-22 2001-03-29 Merck Patent Gmbh Biphenylderivate als NHE-3-Inhibitoren
IL147696A0 (en) * 2001-01-25 2002-08-14 Pfizer Prod Inc Combination therapy
US6423705B1 (en) 2001-01-25 2002-07-23 Pfizer Inc. Combination therapy
US6844361B2 (en) 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
MXPA04007569A (es) * 2002-02-04 2004-11-01 Aventis Pharma Gmbh Preparacion de la combinacion del inhibidor del intercambio sodio-hidrogeno cariporida con inhibidores ace para evitar la insuficiencia cardiaca y otras disfunciones de los organos relacionadas con la edad, padecimientos relacionados con la edad y pa
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
ATE404533T1 (de) * 2003-05-06 2008-08-15 Merck Patent Gmbh Verfahren zur kristallisation von guanidinium- salzen
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7531569B2 (en) 2003-12-02 2009-05-12 Sanofi-Aventis Deutschland Gmbh Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives
DE10356717A1 (de) * 2003-12-02 2005-07-07 Aventis Pharma Deutschland Gmbh Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten
CA2586547A1 (en) * 2004-11-05 2006-05-11 King Pharmaceuticals Research & Development, Inc. Stabilized individually coated ramipril particles, compositions and methods
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
EP3960165A1 (en) * 2020-08-25 2022-03-02 Fondation EspeRare Nhe-1 inhibitors for the treatment of coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2108144T3 (es) 1992-02-15 1997-12-16 Hoechst Ag Benzoilguanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2097409T3 (es) * 1992-09-22 1997-04-01 Hoechst Ag Benzoilguanidinas, procedimiento para su preparacion, asi como su empleo como antiarritmicos.
DE4328869A1 (de) 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432106A1 (de) 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
DE19741635A1 (de) * 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Also Published As

Publication number Publication date
CA2245776A1 (en) 1999-02-27
JP4436940B2 (ja) 2010-03-24
CN1172665C (zh) 2004-10-27
PL195566B1 (pl) 2007-10-31
NO983926L (no) 1999-03-01
KR19990023904A (ko) 1999-03-25
PL328251A1 (en) 1999-03-01
AR017513A1 (es) 2001-09-12
NZ331533A (en) 2000-04-28
EP0937464A3 (de) 2003-09-24
EP0937464A2 (de) 1999-08-25
IL125913A0 (en) 1999-04-11
BR9803233A (pt) 2000-05-02
AU738598B2 (en) 2001-09-20
TW589175B (en) 2004-06-01
CN1209316A (zh) 1999-03-03
US6348476B1 (en) 2002-02-19
NO320264B1 (no) 2005-11-14
RU2227751C2 (ru) 2004-04-27
DE19737224A1 (de) 1999-03-18
SK116798A3 (en) 1999-03-12
TR199801661A2 (xx) 1999-03-22
JPH11139990A (ja) 1999-05-25
EP0937464B1 (de) 2012-07-11
HUP9801924A3 (en) 2004-11-29
HUP9801924A2 (hu) 2000-02-28
HK1018211A1 (en) 1999-12-17
CZ270998A3 (cs) 1999-03-17
HU9801924D0 (en) 1998-10-28
HRP980464A2 (en) 1999-06-30
AU8190898A (en) 1999-03-11
ZA987723B (en) 1999-03-01

Similar Documents

Publication Publication Date Title
NO983926D0 (no) Farmasöytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretslöpsykdommer
NO984107D0 (no) Kappa agnostiske forbindelser og farmasöytiske ormuleringer derav
NO20000932D0 (no) Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant
NO993315D0 (no) Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
NO973283L (no) Konjugater av terapeutisk forbindelse og fettsyre
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO20001001D0 (no) Poly (ADP-ribose) polymerase ("PARP") inhibitorer, fremgangsmõte og farmasøytiske sammensetninger for behandling av neurale og kardiovaskulære vevskader
IS1981B (is) Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
NO20006559D0 (no) Farmasöytisk kombinasjon omfattende en cox-2-inhibitor og en iNOS-inhibitor
FI955311A0 (fi) Farmaseuttinen koostumuspohja
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
NO964102D0 (no) Farmasöytiske preparater og medikamenter for forebyggelse og behandling av endotheliale dysfunksjoner
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
DE69524592D1 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
RU98116126A (ru) Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний
NO20010487D0 (no) Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav
BR9509688A (pt) Composto e composição farmacêutica
NO983678D0 (no) Nye cefemforbindelser og farmasöytiske anvendelser derav
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
DK0889051T3 (da) Triterpenderivater og midler mod leversygdomme
NO984071D0 (no) Anvendelse av hemmere av natrium-hydrogen-veksler for fremstilling av et medikament for redusering av u°nskede virkninger av stoffer pÕ hjerter
NO983943L (no) Anvendelse av inhibitorer av natrium-hydrogen-utvekslere for fremstilling av et legemiddel for behandling av sykdommer forÕrsaket av protozoer